Publications

Selected publications by leading scientists on how anti-VEGF therapy can be improved (more below).

Publications on tele-ophthalmic support improving anti-VEGF outcomes (Münster "Portal").

© Augenzentrum am St. Franziskus-Hospital Münster - visual acuity over 2 years in IVI Portal Münster compared to other real-world studies like AURA

Stable visual acuity (VA) over 2 years in IVI Portal Münster compared to other real-world studies like AURA with below-baseline VA

© Augenzentrum am St. Franziskus-Hospital Münster - persistence over 2 years in IVI Portal Münster compared to other real-world studies like PERSEUS and AURA

Persistence over 2 years in IVI Portal Münster, 2x higher compared to other real-world studies like PERSEUS and AURA (<0.4)

2024 DOG Cogress |  Health services research in retinology | Presentation Fr20f-04 | Spickermann | Analysis of the care model “Portal” - 4-year study of the quality of outcome of IVOM therapy with regard to latency times in exudative AMD

Stable visual acuity (VA) over 4-5 years in IVI Portal Münster

Selected publications by leading scientists on how AI can provide a 2nd opinion for anti-VEGF therapy.

2023 EURETINA | Gutfleisch et al. | A Post Hoc Analysis of intravitreal aflibercept–treated nAMD Patients from ARIES & ALTAIR: Predicting Patient-Individualized Treatment Interval for aflibercept Treat-And-Extend Therapy Regimen by Adapting AI Algorithms Trained on Pro-Re-Nata Data

2022 DOG PFr05-05 | Gutfleisch et al. | Annotation of SD-OCT biomarkers in nAMD for the development of explainable AI models (XAI).

2023 DOG PDo04-05 | Gutfleisch et al. | Validation of an AI algorithm for detection and grading of SD-OCT biomarkers in neovascular AMD (nvAMD) using an external real-life data set

2022 DOG PDo04-11 | Rothaus et al. | Predicting the need for therapy in neovascular AMD (nAMD) using annotation-based deep learning models.

2023 EVER | Assaf et al. | Detection of Subretinal and Intraretinal Fluids in Optopol SD-OCT Using Transfer Learning

You Want to Get Involved in AI, too?

Watch replays of public talks by us

2022 Oracles of Eye Innovation Webinar XII

2023 Talk at Deutsches Museum (German only)

More publications by leading scientists on AI in ophthalmology.

More publications by leading scientists on how anti-VEGF therapy can be improved.

© deepeye Medical - Dr. Autumn Lang, Director Clincal Affairs

Autumn Lang, Ph.D., RAC, Director Clinical Affairs

Anything missing?

Should we not have what you are looking for, we are happy to point you to other studies without our involvement. In any case, reach out to us! suggest changing to: Reach out to us, we welcome the opportunity to collaborate and refer you to any relevant studies (even those outside of our own studies)!